Advertisement
New Zealand markets closed
  • NZX 50

    12,105.29
    +94.63 (+0.79%)
     
  • NZD/USD

    0.5984
    -0.0022 (-0.36%)
     
  • NZD/EUR

    0.5537
    -0.0006 (-0.11%)
     
  • ALL ORDS

    8,153.70
    +80.10 (+0.99%)
     
  • ASX 200

    7,896.90
    +77.30 (+0.99%)
     
  • OIL

    82.65
    +1.30 (+1.60%)
     
  • GOLD

    2,236.30
    +23.60 (+1.07%)
     
  • NASDAQ

    18,281.63
    +0.79 (+0.00%)
     
  • FTSE

    7,970.37
    +38.39 (+0.48%)
     
  • Dow Jones

    39,776.27
    +16.19 (+0.04%)
     
  • DAX

    18,511.14
    +34.05 (+0.18%)
     
  • Hang Seng

    16,541.42
    +148.58 (+0.91%)
     
  • NIKKEI 225

    40,168.07
    -594.66 (-1.46%)
     
  • NZD/JPY

    90.4100
    -0.3700 (-0.41%)
     

Capital Market Laboratories (CMLviz) One-on-One with Livongo Health CEO: Major acceleration in tele-health and remote patient monitoring together with its whole chronic condition platform yields a ‘massive, massive market.’

LOS ANGELES, June 12, 2020 (GLOBE NEWSWIRE) -- In an interview with Capital Market Laboratories (CMLviz), Chief Executive Office Officer of Livongo Health (LVGO) had a clear message:

  1. The company has seen a major acceleration in tele-health and remote patient monitoring which ‘would’ve taken years to have occurred without this pandemic.’

  2. Remote health monitoring will become the standard of care.

  3. The company has utilized the entire health ecosystem to create multiplication for Livongo.

  4. Livongo’s total addressable market today for diabetes management and hypertension is nearly $50 billion. As the firm continues to add weight management and behavioral health and then extends its solutions further – ‘it’s just a massive, massive market place for us.’

In a far-ranging interview with the CEO we discussed the future of the business and healthcare.

Read: Livongo CEO Sees a Massive Market Ahead

Media queries
Alicia Newman, Director Client Services
Capital Market Laboratories
support@cmlviz.com